© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 07, 2021
For this Mother’s Day, Caroline Carney, MD, MSc, FAPM, CPHQ, explains the importance of understanding the correlation between mental health and heart health in women aged 65 years and older.
May 05, 2021
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
May 04, 2021
Previous studies found breastfeeding does not impact executive function or memory, which was similar to the findings in this study, according to the authors.
April 28, 2021
Preliminary study results showed no safety concerns among pregnant women that received Pfizer-BioNTech and Moderna COVID-19 vaccines.
Women who had migraines before menopause had a 29% increased risk of developing high blood pressure after menopause.
April 27, 2021
Researchers from the University of Pennsylvania School of Medicine have identified additional genetic mutations that strongly predispose otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through 5 months after delivery.
April 23, 2021
According to the study authors, the findings suggest a need for greater transparency in health care pricing as well as policies eliminating financial obstacles to catching cancer early.
The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.
April 22, 2021
The risk peaks close to delivery and then improves by 1 year after delivery, though a modest risk of developing kidney stones continues beyond 1 year after delivery.
There have now been approximately 70,000 pregnant people vaccinated against COVID-19 with no evidence of harm.